Asia Pacific: The blood screening market in Asia Pacific is anticipated to experience rapid growth, primarily driven by countries such as China, Japan, and South Korea. Rising healthcare expenditure, increasing awareness about blood safety, and the presence of a large patient pool are contributing to market growth in this region.
Europe: In Europe, countries like the United Kingdom, Germany, and France are expected to be key contributors to the blood screening market. Stringent regulations regarding blood safety and the presence of advanced healthcare facilities are fueling market growth in these countries. Increasing prevalence of chronic diseases and growing demand for blood transfusions are further driving market growth in Europe.